The Peptide Company – Navbar

Retatrutide (Reta)

£84.99

Availability: 6 in stock

ProductAmountDiscount
Buy 2 - Save £152 £7.50 flat
Buy 3 - Save £403 - 4 £13.33 flat
Buy 5 - Save £905 + £18.00 flat
SKU: RETATRUTIDE20MG Category: Tags: , ,

Strictly for Research Purposes Only
This product: Retatrutide is not intended for human consumption, diagnostic, or therapeutic use. It has not been evaluated or approved by the FDA. Misuse is strictly prohibited and may result in legal consequences.
Retatrutide Purity
≥99%
Receptor Targets
GLP-1, GIP & GCGR
Form
Lyophilized Powder
Storage
-20°C
🔬 Technical Specifications
Retatrutide (LY3437943)
Molecular Formula
C221H342N46O68
Molecular Weight
~4731.4 g/mol
AMOUNT PER VIAL
20mg per vial
Packaging
Sterile 2ml vials
Shipping & Handling
✓ Shipped in temperature-controlled packaging
✓ Same-day dispatch for orders before 2PM
✓ Discrete, plain packaging
🧪 Scientific Background
Retatrutide is an investigational single peptide with agonist activity at the glucose-dependent insulinotropic polypeptide (GIP), GLP-1, and glucagon receptors. Because of this unique “triple agonist” mechanism, it is widely studied for its profound effects on weight regulation and metabolic health.
Mechanism of Action: By simultaneously activating GLP-1, GIP, and glucagon receptors, retatrutide targets multiple metabolic pathways. GLP-1 and GIP agonism support insulin regulation and satiety, while glucagon receptor agonism increases energy expenditure and promotes fat oxidation.
Reconstitution: Requires reconstitution with bacteriostatic water or another suitable solvent before use. Store at –20°C for long-term stability and protect from light.
Research Applications
• Appetite regulation and satiety signalling
• Energy expenditure and thermogenesis
• Glucose metabolism and insulin sensitivity
• Body composition and fat mass reduction

Scientific Studies: Efficacy & Safety

  • Triple-Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial
    Jastreboff AM, et al. (NEJM, 2023)

    • Key Findings: A 48-week, phase 2 trial involving adults with obesity showed that retatrutide treatment resulted in substantial reductions in body weight. Participants receiving the highest dose experienced a mean weight reduction of 24.2% at 48 weeks.
    • PubMed Link
  • Retatrutide for people with type 2 diabetes: a phase 2 trial
    Rosenstock J, et al. (The Lancet, 2023)

    • Key Findings: In participants with type 2 diabetes, retatrutide showed clinically meaningful improvements in glycaemic control and robust reductions in body weight. The safety profile was consistent with other incretin-based therapies, with mostly mild-to-moderate gastrointestinal side effects.
    • PubMed Link
Verified Feedback

Customer Reviews

Customer feedback for The Peptide Company products.

★★★★★

Cutting-Edge Research Tool

Retatrutide from The Peptide Company has been a breakthrough for my studies on metabolic regulation. The product is of exemplary quality, with reliable purity and potency. It arrived quickly, securely packaged, and with a clear COA for peace of mind. I’m thoroughly impressed and will be reordering!

★★★★★

Unmatched Quality for Research

I’ve been using Retatrutide for advanced research, and The Peptide Company’s product has delivered fantastic results. The purity and consistency of the peptide are outstanding, and I appreciate the transparency with third-party testing. Shipping was efficient, and the packaging was top-notch. Highly recommend!

Additional information

Research Applications of Retatrutide

Retatrutide has become one of the most discussed investigational compounds in metabolic research due to its unique triple receptor activity. Researchers continue to explore its potential applications across several scientific disciplines.

Areas of interest include:

  • Weight Regulation Research: Scientists investigate how simultaneous activation of GLP-1, GIP and glucagon receptors may influence appetite signalling, energy expenditure and metabolic efficiency.
  • Metabolic Health Studies: Retatrutide is frequently examined in research involving insulin sensitivity, glucose regulation and overall metabolic function.
  • Energy Expenditure Research: Unlike traditional GLP-1 receptor agonists, Retatrutide’s glucagon receptor activity has generated interest regarding thermogenesis and energy utilisation.
  • Body Composition Studies: Researchers continue to evaluate changes in fat distribution, lean mass retention and long-term weight management outcomes.
  • Cardiovascular Research: Several ongoing investigations explore relationships between metabolic improvement and cardiovascular risk markers including lipid profiles and inflammatory indicators.

As research progresses, Retatrutide continues to be studied within controlled laboratory environments to better understand its mechanisms and potential scientific applications.

Storage and Handling Guidelines

Proper storage is essential for maintaining peptide integrity throughout research activities.

  • Lyophilised Powder: Prior to reconstitution, Retatrutide is typically stored frozen at approximately -20°C.
  • Reconstituted Material: Once reconstituted, researchers generally store solutions under refrigerated conditions and utilise them within suitable laboratory timeframes.
  • Light Protection: Peptides should be protected from direct sunlight and prolonged exposure to heat.
  • Temperature Stability: Repeated freeze-thaw cycles may affect peptide stability and should generally be avoided where possible.

Laboratory Best Practice

  • Use sterile laboratory procedures
  • Handle materials with appropriate PPE
  • Maintain accurate documentation
  • Store products in designated research environments
  • Follow all institutional handling protocols

Storage requirements may vary depending on research methodology and laboratory conditions.

Understanding Triple Agonist Research

Retatrutide is classified as a triple agonist because it interacts with three distinct receptor systems involved in metabolic regulation.

  • GLP-1 Receptor Activity: GLP-1 receptors play a role in appetite signalling and glucose regulation. Research in this area focuses on how receptor activation may influence feeding behaviour and metabolic responses.
  • GIP Receptor Activity: GIP receptors have attracted significant scientific interest due to their potential involvement in nutrient utilisation and insulin-related pathways.
  • Glucagon Receptor Activity: The glucagon component differentiates Retatrutide from many earlier investigational compounds. Researchers continue to study its role in energy expenditure and metabolic flexibility.

Why Researchers Are Interested

The combination of all three pathways allows scientists to investigate:

  • Appetite regulation
  • Energy expenditure
  • Glucose metabolism
  • Fat oxidation
  • Body composition changes
  • Metabolic adaptation

This multi-pathway approach has contributed to the increasing volume of published research involving Retatrutide and similar next-generation metabolic compounds.

Retatrutide Research FAQ

What is Retatrutide?
Retatrutide is an investigational peptide studied for its activity at GLP-1, GIP and glucagon receptors.
What makes Retatrutide different from other metabolic research compounds?
Its triple agonist mechanism distinguishes it from compounds that target only one or two receptor pathways.
Is this product intended for human consumption?
No. This product is supplied strictly for laboratory and research purposes.
What form is supplied?
Retatrutide is supplied as a lyophilised powder.
What does lyophilised mean?
Lyophilisation is a freeze-drying process commonly used to improve peptide stability during storage and transport.
How should the product be stored?
Researchers generally store lyophilised peptides at frozen temperatures until required for laboratory use.
Why is purity important?
High purity levels help researchers maintain consistency and reliability across studies.
What research fields commonly investigate Retatrutide?
Areas include metabolic research, obesity-related studies, glucose regulation research and energy expenditure investigations.
How is peptide integrity maintained?
Proper storage, handling and laboratory protocols help preserve peptide quality.
Can Retatrutide be combined with other research compounds?
Research methodologies vary significantly. Investigators should determine suitable study designs based on their specific protocols and objectives.

Explore Related Research Guides

Researchers interested in Retatrutide may also find the following resources useful:

These educational resources provide additional information regarding peptide mechanisms, storage considerations, laboratory handling procedures and ongoing areas of scientific investigation.

Reviews

There are no reviews yet.

Be the first to review “Retatrutide (Reta)”

Your email address will not be published. Required fields are marked *

You may also like…

Shopping Cart
Scroll to Top
Checkout Exclusive

Add Gummies to Your Order & Save 50%

Before you complete checkout, add our Himalayan Shilajit Gummies to your order and get an instant 50% discount.

🍬

Himalayan Shilajit Gummies – 3000mg

Limited checkout-only offer. Discount applies only to this gummies product.

Add Gummies & Save 50%